SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-094755
Filing Date
2020-08-13
Accepted
2020-08-13 17:03:11
Documents
1
Period of Report
2020-08-11

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2027548d3_4.html 4  
1 OWNERSHIP DOCUMENT tm2027548d3_4.xml 4 4040
  Complete submission text file 0001104659-20-094755.txt   5691
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 2161401 972-4-988-9488
Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BRAINSTORM CELL THERAPEUTICS INC., 3 UNIVERSITY PLAZA DRIVE, STE 320 HACKENSACK NJ 07601
Business Address
Rubin Eyal (Reporting) CIK: 0001721411 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33357 | Film No.: 201100129